等待开盘 04-01 09:30:00 美东时间
0.000
0.00%
Allarity Therapeutics reported a strengthened financial position in 2025 with a cash balance of $14.7 million and reduced operating expenses. The company received FDA Fast Track designation for stenoparib, showing durable clinical benefit in ovarian cancer patients, with some treated for nearly 30 months. Stenoparib's development expanded into small cell lung cancer through a VA-funded trial. Leadership strengthened with new appointments, and the...
03-31 12:00
Imac Holdings ( ($BACK) ) has shared an update. IMAC Holdings has disclosed tha...
03-20 04:37
Aditxt (ADTX) acquired 100% of Ignite Proteomics from IMAC Holdings plus $475K in cash. The deal consideration was 36,000 Series A-2 convertible preferred shares valued at $36M (stated value $1,000 ea...
03-14 02:25
The latest announcement is out from Imac Holdings ( ($BACK) ). On February 26, ...
02-28 05:49
IMAC Holdings Secures $222,600 Promissory Note Financing IMAC Holdings Inc. has entered into a new secured loan agreement, issuing a promissory note to a lender in the aggregate principal amount of $222,600 for a purchase price of $159,000. The note, which matures on January 31, 2026, allows the com
01-31 05:37
Imac Holdings ( ($BACK) ) has provided an update. On January 15, 2026, IMAC Hol...
01-17 05:39
Imac Holdings ( ($BACK) ) has shared an update. On December 19, 2025, IMAC Hold...
2025-12-31 06:29
IMAC Holdings Inc. has entered into a new secured loan agreement, issuing a promissory note in the principal amount of $245,000 to an unnamed lender for a purchase price of $175,000. The note matures ...
2025-12-02 05:01
Imac Holdings ( ($BACK) ) has issued an announcement. On November 14, 2025, IMA...
2025-11-21 06:19
Imac Holdings ( ($BACK) ) has released a notification of late filing. IMAC Hold...
2025-11-15 07:21